SCHEMBL22497656

SCHEMBL22497656

C=CC(=O)Nc1cc(Nc2ncc(Cl)c(Nc3ccccc3P(C)(C)=O)n2)c(OC)cc1N(C)CCN(C)C

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
EGFR P00533 20/20 1.00
ALK Q9UM73 11/20 1.00
EML4 Q9HC35 9/20 1.00
INSR P06213 2/20 0.74
ERBB2 P04626 1/20 0.74
ROS1 P08922 1/20 0.74
FER P16591 1/20 0.74
LTK P29376 1/20 0.74
BLK P51451 1/20 0.74
PTK2 Q05397 1/20 0.74
BTK Q06187 1/20 0.74
TNK2 Q07912 1/20 0.74
ERBB4 Q15303 1/20 0.74
SLK Q9H2G2 1/20 0.74
IGF1R P08069 3/20 0.65
KCNH2 Q12809 3/20 0.65

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13728805 0.96 EGFR (0.92) EGFRALKEML4INSRERBB2
SCHEMBL13727467 0.94 EGFR (0.88) EGFRALKEML4INSRERBB2
SCHEMBL13726193 0.93 EGFR (0.87) EGFRALKEML4INSRERBB2
SCHEMBL16781046 0.93 EGFR (0.86) EGFRALKEML4INSRERBB2
SCHEMBL22497626 0.92 EGFR (0.85) EGFRALKEML4INSRERBB2
SCHEMBL24178967 0.92 EGFR (0.84) EGFRALKEML4INSRERBB2
SCHEMBL22520213 0.91 EGFR (1.00) EGFRALKEML4INSRERBB2
SCHEMBL13725659 0.89 EGFR (0.81) EGFRALKEML4INSRERBB2
SCHEMBL25005180 0.89 EGFR (0.80) EGFRALKEML4INSRERBB2
SCHEMBL30223153 0.89 EGFR (0.80) EGFRALKEML4INSRERBB2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2020200191-A1 EGFR INHIBITORS, COMPOSITIONS AND METHODS THERE OF BETTA PHARMACEUTICALS CO., LTD (CN) 2020-10-08 WO disclosed
WO-2020200191-A1 EGFR INHIBITORS, COMPOSITIONS AND METHODS THERE OF BETTA PHARMACEUTICALS CO., LTD (CN) 2020-10-08 WO disclosed